Showing results (291-300 of 463) with videos related to
Sort By:
Pageof 47
European Journal of Neurology|February 4, 2009
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosisN Putzki, K Kollia, S Woods, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1987
Medium and long latency EMG responses in leg muscles: Parkinson's diseaseE Scholz, H C Diener, J Noth, et al.Cephalalgia : an International Journal of Headache|September 17, 2002
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response studyV Pfaffenrath, H C Diener, M Fischer, et al.Cephalalgia : an International Journal of Headache|June 4, 2011
Integrated headache careH-C Diener, C Gaul, R Jensen, et al.Stroke|January 1, 1996
Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study GroupH C Diener, W Hacke, M Hennerici, et al.European Neurology|October 25, 2008
Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro studyNorman Putzki, Manoj Kumar, Ernst Kreuzfelder, et al.Fortschritte Der Neurologie-Psychiatrie|December 8, 2010
[Bilateral occipital nerve stimulation for the treatment of chronic cluster headache: case series and initiation of a prospective study]O M Müller, C Gaul, Z Katsarava, et al.Journal of Neurology|August 1, 1986
Incidence of peripheral neuropathy and cerebellar ataxia in chronic alcoholicsE Scholz, H C Diener, J Dichgans, et al.Cephalalgia : an International Journal of Headache|October 1, 2008
Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesicsH-C Diener, V Pfaffenrath, L Pageler, et al.Cephalalgia : an International Journal of Headache|October 20, 2005
Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled studyH C Diener, V Pfaffenrath, J Schnitker, et al.Pageof 47